Value | Coefficient | z | Hazard Ratio | P-value |
---|---|---|---|---|
Overall Survival | ||||
PNET vs Other | −0.2 | −0.5 | 0.8 | 0.6 |
ECOG 1 vs 0 | 0.1 | 0.5 | 1.2 | 0.7 |
ECOG 2 vs 0 | 0.9 | 2.5 | 2.7 | 0.01 |
Extrahepatic Disease | 0.3 | 0.9 | 1.3 | 0.4 |
Unilobar Treatment | −0.5 | −1.9 | 0.6 | 0.06 |
Ascites | 1.0 | 2.0 | 2.8 | 0.049 |
≥ 25% Tumor Burden | −0.3 | −1.1 | 0.7 | 0.3 |
Progression-Free Survival | ||||
PNET vs Other | −0.2 | −0.5 | 0.9 | 0.6 |
ECOG 1 vs 0 | −0.09 | −0.3 | 0.9 | 0.7 |
ECOG 2 vs 0 | 0.9 | 2.5 | 2.4 | 0.01 |
Extrahepatic Disease | 0.4 | 1.4 | 1.4 | 0.2 |
Unilobar Treatment | −0.5 | −2.1 | 0.6 | 0.03 |
Ascites | 1.6 | 3.8 | 4.9 | 0.0001 |
≥ 25% Tumor Burden | −0.5 | −2.0 | 0.6 | 0.049 |